IDEXX Laboratories Inc
IDXX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000874716
In the last 90 days, IDEXX Laboratories Inc insiders filed 0 open-market purchases and 1 sale; 1,306 institutions reported holding it in 13F filings for Q2 2026, worth $39.1B in total; 3 superinvestors hold it, including Fundsmith and Weitz Investment Management.
Q4 2025 vs. Q3 2025
How the institutions holding IDEXX Laboratories Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 1,302 | 28 | 1,385 | +111 |
| Shares | 72.2M | 240.7K | 82.4M | +10.5M (+14.6%) |
| Value | $46.1B | $153.8M | $50.3B | +$4.35B (+9.5%) |
28 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (191)
Institutions that held IDEXX Laboratories Inc at the end of Q4 2025 but not at the end of Q3 2025.
Showing the largest 100 of 191 by value.
Sold out (80)
Institutions that held IDEXX Laboratories Inc at the end of Q3 2025 and filed for Q4 2025 without it.
Not filed for Q4 2025 yet (28)
Institutions that held IDEXX Laboratories Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.